Actuate Therapeutics Inc (ACTU)
SG&A Expense Growth
88.18%
Fiscal year · Period ending:
ACTU SG&A Expense Growth
Latest reported88.18%period ending
Latest reported88.18%period ending
ACTU FY SG&A Growth (YoY) (0.00% → 88.18%)
Latest values, visible window
High-resolution chart · PNG
ACTU sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 88.1837% | |
| 98.5749% | |
| -14.5066% | |
| 0% |